Drug Trial Radar · NCT06592274
A Phase 2 Study of HB0017 in Psoriasis Patients
Last checked: Nov 19, 2026Latest source record: Oct 23, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
206
Actual
Start
Sep 30, 2024
Primary completion
Apr 30, 2025
Study completion Apr 10, 2026
Sponsor
- Lead sponsor
- Huabo Biopharm Co., Ltd.Industry
- Sponsor type
- Industry
- First posted
- Sep 19, 2024
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is a randomized, double-blind phase 2 clinical trial aimed at exploring the efficacy, safety, and immunogenicity of HB0017 injection with different dosing regimens in the treatment of moderate to severe plaque psoriasis in subjects
Conditions
- Psoriasis (PsO)
Interventions
HB0017Biological
300mg Q12W
HB0017Biological
300mg Q8W
HB0017Biological
150mg Q4W
Primary outcomes
What the sponsor says the trial is designed to measure.
- Proportion of subjects achieving PASI 90 responseTime frame: Week 12
- Proportion of subjects achieving sPGA 0/1Time frame: Week 12
Locations
18 sites in 1 country. Site status is shown where the registry gives one.
Guangdong Provincial People's Hospital
Guangzhou, China
Ningbo Second Hospital
Ningbo, China
The First Affiliated Hospital of Bengbu Medical College
Bengbu, Anhui, China
Southern Medical University Dermatology Hospital
Guangzhou, Guangdong, China
Xiangya Hospital of Central South University
Changsha, Hunan, China
Wuxi Second People's Hospital
Wuxi, Jiangsu, China
Jiangsu University Affiliated Hospital
Zhenjiang, Jiangsu, China
Jilin University Second Hospital
Changchun, Jilin, China
Shandong First Medical University Affiliated Dermatology Hospital
Jinan, Shandong, China
Jining First People's Hospital
Jining, Shandong, China
Xingtai People's Hospital
Xingtai, Shandong, China
Shanxi Medical University Second Hospital
Taiyuan, Shanxi, China
Sichuan Provincial People's Hospital
Chengdu, Sichuan, China
Chongqing Traditional Chinese Medicine Hospital
Chongqing, Sichuan, China
Hangzhou First People's Hospital
Hangzhou, Zhejiang, China
The First Affiliated Hospital of Zhejiang University School of Medicine
Hangzhou, Zhejiang, China
Jiaxing First Hospital
Jiaxing, Zhejiang, China
Wenzhou Medical University Affiliated First Hospital
Wenzhou, Zhejiang, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.